Sona Nanotech Inc. (SNANF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 527.68 Thousand CAD | -13.28% |
| 2022 | 608.46 Thousand CAD | -54.46% |
| 2021 | 1.33 Million CAD | -10.38% |
| 2020 | 1.49 Million CAD | 28.13% |
| 2019 | 1.16 Million CAD | 6.58% |
| 2018 | 1.09 Million CAD | 165.81% |
| 2017 | 410.7 Thousand CAD | -30.64% |
| 2016 | 592.17 Thousand CAD | -73.21% |
| 2015 | 2.21 Million CAD | 20.7% |
| 2014 | 1.83 Million CAD | 89.36% |
| 2013 | 967.12 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 587.18 Thousand CAD | 3.63% |
| 2024 Q1 | 546.81 Thousand CAD | 3.63% |
| 2024 Q2 | 566.63 Thousand CAD | 3.63% |
| 2023 FY | 527.68 Thousand CAD | -13.28% |
| 2023 Q2 | 653.28 Thousand CAD | 3.61% |
| 2023 Q4 | 527.68 Thousand CAD | -22.03% |
| 2023 Q1 | 630.5 Thousand CAD | 3.62% |
| 2023 Q3 | 676.81 Thousand CAD | 3.6% |
| 2022 Q2 | 752.49 Thousand CAD | 3.63% |
| 2022 Q3 | 587.17 Thousand CAD | -21.97% |
| 2022 Q4 | 608.46 Thousand CAD | 3.63% |
| 2022 FY | 608.46 Thousand CAD | -54.46% |
| 2022 Q1 | 726.16 Thousand CAD | -45.65% |
| 2021 Q1 | 1.59 Million CAD | 7.18% |
| 2021 Q3 | 1.6 Million CAD | 0.33% |
| 2021 FY | 1.33 Million CAD | -10.38% |
| 2021 Q4 | 1.33 Million CAD | -16.93% |
| 2021 Q2 | 1.6 Million CAD | 0.33% |
| 2020 Q3 | 978.33 Thousand CAD | 0.0% |
| 2020 Q1 | 682.52 Thousand CAD | -41.34% |
| 2020 FY | 1.49 Million CAD | 28.13% |
| 2020 Q4 | 1.49 Million CAD | 52.38% |
| 2020 Q2 | 978.33 Thousand CAD | 43.34% |
| 2019 Q2 | 1.29 Million CAD | 71.93% |
| 2019 FY | 1.16 Million CAD | 6.58% |
| 2019 Q1 | 753.4 Thousand CAD | -30.99% |
| 2019 Q4 | 1.16 Million CAD | -3.31% |
| 2019 Q3 | 1.2 Million CAD | -7.1% |
| 2018 Q3 | 420.7 Thousand CAD | 0.0% |
| 2018 Q1 | 418.2 Thousand CAD | 1.83% |
| 2018 FY | 1.09 Million CAD | 165.81% |
| 2018 Q4 | 1.09 Million CAD | 159.49% |
| 2018 Q2 | 420.7 Thousand CAD | 0.6% |
| 2017 Q3 | 352.92 Thousand CAD | -10.81% |
| 2017 Q2 | 395.7 Thousand CAD | -9.76% |
| 2017 Q1 | 438.48 Thousand CAD | -25.95% |
| 2017 FY | 410.7 Thousand CAD | -30.64% |
| 2017 Q4 | 410.7 Thousand CAD | 16.37% |
| 2016 Q4 | 592.17 Thousand CAD | -6.49% |
| 2016 FY | 592.17 Thousand CAD | -73.21% |
| 2016 Q3 | 633.29 Thousand CAD | -1.18% |
| 2016 Q2 | 640.84 Thousand CAD | -71.11% |
| 2016 Q1 | 2.21 Million CAD | 0.34% |
| 2015 Q3 | 2.29 Million CAD | 12.61% |
| 2015 Q4 | 2.21 Million CAD | -3.85% |
| 2015 Q2 | 2.04 Million CAD | 11.47% |
| 2015 Q1 | 1.83 Million CAD | 0.0% |
| 2015 FY | 2.21 Million CAD | 20.7% |
| 2014 FY | 1.83 Million CAD | 89.36% |
| 2014 Q2 | 996.12 Thousand CAD | 1.48% |
| 2014 Q3 | 1.78 Million CAD | 79.55% |
| 2014 Q4 | 1.83 Million CAD | 2.39% |
| 2014 Q1 | 981.62 Thousand CAD | 1.5% |
| 2013 Q4 | 967.12 Thousand CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 FY | 967.12 Thousand CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 76.443% |
| Arrayit Corporation | 1.07 Million USD | 51.058% |
| Atlantic International Corp. | 2.93 Million USD | 81.993% |
| Biocept, Inc. | 12.1 Million USD | 95.642% |
| Bioqual, Inc. | 3.58 Million USD | 85.289% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -626.693% |
| DermTech, Inc. | 54.39 Million USD | 99.03% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.888% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 89.084% |
| iMD Companies, Inc. | 1.12 Million USD | 52.892% |
| IDenta Corp. | 789.14 Thousand USD | 33.133% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 95.285% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -1103.515% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 93.441% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 86.208% |
| NovelStem International Corp. | 3.57 Million USD | 85.238% |
| Optigenex Inc. | 8.94 Million USD | 94.098% |
| PharmChem, Inc. | 77.35 Thousand USD | -582.173% |
| Proteome Sciences plc | 17.15 Million USD | 96.924% |
| Response Genetics, Inc | 6.37 Million USD | 91.72% |
| Rennova Health, Inc. | 15.32 Million USD | 96.558% |
| RushNet, Inc. | 4.82 Million USD | 89.059% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -154.876% |
| Stella Diagnostics Inc. | 6.2 Million USD | 91.49% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 70.686% |
| Todos Medical Ltd. | 38.34 Million USD | 98.624% |